Saturday 7 November 2026 Export URGN’s income statement to Excel — free account

Urogen Pharma

URGN Healthcare Biotechnology

Urogen Pharma’s revenue for fiscal 2025 (year ended December 2025) was $109.8 million, up 21.4% from fiscal 2024.

Revenue: +223.9%
EPS: +95.8%
Free cash flow: +64.0%
Total debt: +57.2%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

24.81 0.92 −3.58%

Follow URGN

Alert me

Market cap: $1.3B
P/E: 0.0×
Fwd P/E: −161×
Dividend yield: —
F-score: 2/9
Altman Z: −5.16
Beneish M: −1.42
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	2	3	3	3
ROE Full definition →		268.63%	156.08%	86.49%	54.65%
ROA Full definition →		(63.14%)	(53.15%)	(42.33%)	(28.78%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(109.45%)	(71.07%)	(56.08%)	(36.84%)
Average Days of Receivables Full definition →		109.98	143.96	171.65	171.06
Free Cash Flow per Share Full definition →		(3.38)	(3.31)	(3.16)	(2.61)
Free Cash Flow Full definition →		(162.73)	(166.03)	(159.13)	(132.05)
Capital Expenditures Full definition →		(0.29)	(0.30)	(0.22)	(0.20)
Other line items
Cash ROIC Full definition →		(114.59%)	(80.26%)	(94.40%)	(83.26%)
Accounts Receivable Turnover Full definition →		4.11	3.74	3.48	3.65
Accounts Payable Turnover Full definition →		0.45	0.43	0.49	0.59
Inventory Turnover Full definition →		0.97	1.00	1.09	1.28
Average Days of Payables Full definition →		812.78	904.97	843.84	795.22
Days of Inventory on Hand Full definition →		482.80	535.65	519.45	426.93
Tax Rate Full definition →		0.00	(0.04)	0.00	0.02
Research and Development Expense of Revenue Full definition →		61.12%	44.72%	32.46%	29.25%
Selling, General and Administrative Expense of Revenue Full definition →		141.27%	122.15%	93.71%	74.52%
Share Based Compensation of Revenue Full definition →		10.89%	9.62%	8.54%	7.73%
Interest Coverage Full definition →		(8.14)	(7.00)	(4.11)	(1.92)
Operating CF/Net income Full definition →		1.06	1.24	1.63	2.01
Depreciation/Fixed assets Full definition →		(2.46)	(1.24)	(2.62)	(2.66)
Capex/Depreciation Full definition →		0.18	0.39	0.14	0.13
Revenue per Share Full definition →		2.28	2.80	3.75	4.95
Operating CF per Share Full definition →		(3.38)	(3.30)	(3.15)	(2.61)
Capex per Share Full definition →		(0.01)	(0.01)	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly